U.S. market Closed. Opens in 16 hours 58 minutes

SLS | SELLAS Life Sciences Group, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
RevenueN/A1.00M7.60M1.90MN/AN/AN/AN/AN/A9.32M2.49MN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A100.00K200.00KN/AN/AN/AN/AN/AN/A1.40M520.00KN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/A900.00K7.40M1.90MN/AN/AN/AN/AN/A7.92M1.97MN/AN/AN/AN/AN/AN/AN/A
Operating Expenses37.87M42.85M32.69M18.88M17.21M31.09M21.16M31.87M34.22M60.14M35.81M21.20M20.79M16.62M17.52M14.55MN/AN/A
Selling, General & Admin13.86M12.58M11.32M9.60M9.92M12.77M15.09M12.01M10.61M31.34M14.60M6.58MN/A8.75M8.63MN/AN/AN/A
Research & Development24.01M30.27M21.37M9.28M7.29M18.32M6.07M19.86M23.61M28.35M21.08M14.61M11.54M7.87M8.89M7.05M6.75M1.30M
Other Operating ExpensesN/A10.00M5.70MN/AN/A-3.03MN/AN/AN/A440.00K131.00KN/A9.25MN/AN/A7.50MN/AN/A
Operating Income-37.87M-41.95M-25.29M-16.98M-20.04M-31.09M-23.04M-31.87M-34.22M-52.22M-33.84M-21.20M-20.79M-16.62M-17.52M-14.55M-11.41M-2.40M
Other Expenses / Income529.00K649.00K4.36M208.00K668.00K2.31M-462.00K21.01M-4.37M15.62M-41.79M-13.18M9.30M4.63M-867.00K180.00K448.00KN/A
Before Tax Income-37.34M-41.30M-20.94M-16.77M-19.37M-29.05M-23.50M-10.86M-38.59M-36.61M-75.63M-34.38M-11.48MN/A-18.39M-14.37M-10.96M-2.40M
Income Tax Expenses-37.87M-649.00K-237.00K-17.00K-81.00K-1.38M253.00K243.00K365.00KN/A1.05M-1.05MN/AN/AN/AN/A25.00KN/A
Net Income-37.34M-40.65M-20.70M-16.76M-19.29M-27.67M-23.75M-23.55M-63.90M-36.61M-76.68M-34.97M-11.48M-11.99M-18.39M-14.37M-10.99M-2.40M
Interest ExpensesN/A-649.00KN/AN/A118.00K266.00K462.00K3.51M760.00K1.11M807.00K33.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding27.78M19.40M15.48M7.98M2.56M261.54K46.81K6.64K5.17K3.98K3.01K2.08K1.21K612.00540.00458.00422.00420.00
Diluted Shares Outstanding27.78M19.40M15.48M7.98M2.56M261.54K46.81K6.64K5.17K3.98K3.01K2.08K1.21K612.00540.00458.00422.00420.00
EBITDA-37.87M-42.28M-29.65M-16.88M-14.93M-33.40M-23.04M-31.73M-33.87M-34.61M-74.37M-21.15M-20.62M-16.45M-17.36M-14.42M-11.38M-2.40M
EBITDA Margin0.00%-4,228.20%-390.08%-888.53%0.00%0.00%0.00%0.00%0.00%-371.36%-2,990.23%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-75.21M-41.95M-20.94M-16.77M-19.25M-28.78M-23.04M-19.80M-62.78M-35.50M-74.82M-35.99M-11.48M-11.99M-18.39M-14.37M-10.96M-2.40M
EBIT Margin0.00%-4,195.00%-275.47%-882.84%0.00%0.00%0.00%0.00%0.00%-380.90%-3,008.40%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙